Exact Mass: 469.3152
Exact Mass Matches: 469.3152
Found 237 metabolites which its exact mass value is equals to given mass value 469.3152
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Neomethymycin
A twelve-membered macrolide antibiotic that is biosynthesised by Streptomyces venezuelae.
Methymycin
A twelve-membered macrolide antibiotic that is biosynthesised by Streptomyces venezuelae.
ebastine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Ebastine (LAS-W 090) is an orally active, second-generation histamine H1 receptor antagonist. Ebastine can be used for the symptoms of allergic rhinitis and chronic idiopathic urticaria research[1].
Ebastine
Ebastine (trade names Evastin, Kestine, Ebastel, Aleva) is a non-sedating H1 antihistamine. It does not penetrate the blood–brain barrier and thus allows an effective block of the H1 receptor in peripheral tissue without a central side effect, i. e not causing sedation or drowsiness. The basic patent for ebastine in Europe is EP-B-134124. It is often provided in micronised form, due to poor water solubility. (Wikipedia) CYP2J2, an arachidonic acid epoxygenase, is recognized for its role in the first-pass metabolism of astemizole and ebastine. (PMID: 22328583) R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Ebastine (LAS-W 090) is an orally active, second-generation histamine H1 receptor antagonist. Ebastine can be used for the symptoms of allergic rhinitis and chronic idiopathic urticaria research[1].
N-Nervonoyl Cysteine
N-nervonoyl cysteine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Nervonic acid amide of Cysteine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Nervonoyl Cysteine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Nervonoyl Cysteine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Artefenomel
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides
1-[(1S,4S,5R)-1,4-dimethyl-2,8-dioxabicyclo[3.2.1]octan-4-yl]-3-[(1R,2S,3R,10R,13R,14S)-1-methyl-14-propan-2-yl-12-azapentacyclo[8.6.0.0^{2,13.0^{3,7.0^{7,12]hexadecan-2-yl]propan-1-one
tumonoic acid G
A natural product found particularly in Oscillatoria margaritifera and Oscillatoria margaritifera.
(8E,12E)-3-benzyl-15-sec-butyl-11-hydroxy-6,8,10,12,14-pentamethyl-1-oxa-4-azacyclopentadeca-8,12-diene-2,5-dione
Hypaconine
A diterpene alkaloid with formula C24H39NO8, originally isolated from Aconitum carmichaeli. Hypaconine is a C19-diterpenoid alkaloid isolated from Aconitum and Delphinium spp. Hypaconine?exhibits strong cardiac activity[1].
Ebastin
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist CONFIDENCE standard compound; INTERNAL_ID 2512 COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 8493 Ebastine (LAS-W 090) is an orally active, second-generation histamine H1 receptor antagonist. Ebastine can be used for the symptoms of allergic rhinitis and chronic idiopathic urticaria research[1].
Ile Ile Lys Pro
Ile Ile Pro Lys
Ile Ile Pro Gln
Ile Ile Gln Pro
Ile Lys Ile Pro
Ile Lys Leu Pro
Ile Lys Pro Ile
Ile Lys Pro Leu
Ile Leu Lys Pro
Ile Leu Pro Lys
Ile Leu Pro Gln
Ile Leu Gln Pro
Ile Pro Ile Lys
Ile Pro Ile Gln
Ile Pro Lys Ile
Ile Pro Lys Leu
Ile Pro Leu Lys
Ile Pro Leu Gln
Ile Pro Gln Ile
Ile Pro Gln Leu
Ile Gln Ile Pro
Ile Gln Leu Pro
Ile Gln Pro Ile
Ile Gln Pro Leu
Lys Ile Ile Pro
Lys Ile Leu Pro
Lys Ile Pro Ile
Lys Ile Pro Leu
Lys Leu Ile Pro
Lys Leu Leu Pro
Lys Leu Pro Ile
Lys Leu Pro Leu
Lys Pro Ile Ile
Lys Pro Ile Leu
Lys Pro Leu Ile
Lys Pro Leu Leu
Leu Ile Lys Pro
Leu Ile Pro Lys
Leu Ile Pro Gln
Leu Ile Gln Pro
Leu Lys Ile Pro
Leu Lys Leu Pro
Leu Lys Pro Ile
Leu Lys Pro Leu
Leu Leu Lys Pro
Leu Leu Pro Lys
Leu Leu Pro Gln
Leu Leu Gln Pro
Leu Pro Ile Lys
Leu Pro Ile Gln
Leu Pro Lys Ile
Leu Pro Lys Leu
Leu Pro Leu Lys
Leu Pro Leu Gln
Leu Pro Gln Ile
Leu Pro Gln Leu
Leu Gln Ile Pro
Leu Gln Leu Pro
Leu Gln Pro Ile
Leu Gln Pro Leu
Pro Ile Ile Lys
Pro Ile Ile Gln
Pro Ile Lys Ile
Pro Ile Lys Leu
Pro Ile Leu Lys
Pro Ile Leu Gln
Pro Ile Gln Ile
Pro Ile Gln Leu
Pro Lys Ile Ile
Pro Lys Ile Leu
Pro Lys Leu Ile
Pro Lys Leu Leu
Pro Leu Ile Lys
Pro Leu Ile Gln
Pro Leu Lys Ile
Pro Leu Lys Leu
Pro Leu Leu Lys
Pro Leu Leu Gln
Pro Leu Gln Ile
Pro Leu Gln Leu
Pro Gln Ile Ile
Pro Gln Ile Leu
Pro Gln Leu Ile
Pro Gln Leu Leu
Pro Arg Val Val
Pro Val Arg Val
Pro Val Val Arg
Gln Ile Ile Pro
Gln Ile Leu Pro
Gln Ile Pro Ile
Gln Ile Pro Leu
Gln Leu Ile Pro
Gln Leu Leu Pro
Gln Leu Pro Ile
Gln Leu Pro Leu
Gln Pro Ile Ile
Gln Pro Ile Leu
Gln Pro Leu Ile
Gln Pro Leu Leu
Arg Pro Val Val
Arg Val Pro Val
Arg Val Val Pro
Val Pro Arg Val
Val Pro Val Arg
Val Arg Pro Val
Val Arg Val Pro
Val Val Pro Arg
Val Val Arg Pro
cyclohexyl amide
2-[[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]methyl]oxirane,2-piperazin-1-ylethanamine
2-Dimethylaminoethyl-1,10-dimethyl-2,7-dihydrotetraphyllinate
tert-butyl 4-[4-[6-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]pyrazol-1-yl]piperidine-1-carboxylate
(10S,13S)-13-(hydroxymethyl)-5-[(3R)-6-hydroxy-3,6,7-trimethyloct-1-en-3-yl]-9-methyl-10-propan-2-yl-3,9,12-triazatricyclo[6.6.1.04,15]pentadeca-1,4,6,8(15)-tetraen-11-one
(2S,4aS,6aS,6bR,10R,12aS)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylate
[3-carboxy-2-[(9Z,12E)-10-nitrooctadeca-9,12-dienoyl]oxypropyl]-trimethylazanium
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylate
Gln-Leu-Leu-Pro
A tetrapeptide composed of L-glutamine, two L-leucine units and L-proline joined in sequence by peptide linkages.
1alpha,6alpha,16beta-Trimethoxy-4-(methoxymethyl)-20-methylaconitane-8,13,14alpha,15alpha-tetrol
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]pyrazine-2-carboxamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(5-pyrimidinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(5-pyrimidinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(5-pyrimidinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(5-pyrimidinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(5-pyrimidinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(5-pyrimidinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(5-pyrimidinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
(2E)-21-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]henicos-2-enoate
(E,20R)-20-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyhenicos-2-enoate
[(2S,3S,4R)-2-azaniumyl-3,4-dihydroxy-15-methylhexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
2-[[(2S,3S,4R)-2-amino-3,4-dihydroxy-15-methylhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]docosa-4,7,10,13,16,19-hexaenamide
(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]octadeca-3,6,9,12,15-pentaenamide
(4Z,7Z,10Z,13Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]hexadeca-4,7,10,13-tetraenamide
2-[2,3-Di(trimethylsilyloxy)butoxy]-N-[2-(diethylamino)ethyl]-3-pyridinecarboxamide
1-(2-methoxy-hexadecanyl)-sn-glycero-3-phosphoethanolamine
1-(2-methoxy-14-methyl-pentadecanyl)-sn-glycero-3-phosphoethanolamine
1-(2-methoxy-13-methyl-pentadecanyl)-sn-glycero-3-phosphoethanolamine
oscr#37(1-)
A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#37, obtained by deprotonation of the carboxy group; major species at pH 7.3.